These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12053019)

  • 1. Evaluation of prognostic factors in radical prostatectomy specimens with cancer.
    Mazzucchelli R; Santinelli A; Lopez-Beltran A; Scarpelli M; Montironi R
    Urol Int; 2002; 68(4):209-15. PubMed ID: 12053019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors in prostate needle biopsy.
    Mazzucchelli R; Lopéz-Beltran A; Scarpelli M; Montironi R
    Pathologica; 2002 Dec; 94(6):331-7. PubMed ID: 12541000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance.
    Montironi R; Mazzucchelli R; Kwast T
    Virchows Arch; 2003 Mar; 442(3):211-7. PubMed ID: 12647209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens.
    Epstein JI
    J Urol; 2011 Sep; 186(3):790-7. PubMed ID: 21788055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in prostate cancer. Key elements in structured histopathology reporting of radical prostatectomy specimens.
    Kench JG; Clouston DR; Delprado W; Eade T; Ellis D; Horvath LG; Samaratunga H; Stahl J; Stapleton AM; Egevad L; Srigley JR; Delahunt B
    Pathology; 2011 Aug; 43(5):410-9. PubMed ID: 21716159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of radical prostatectomy specimens and diagnostic reporting of pathological findings.
    Montironi R; Lopez-Beltran A; Mazzucchelli R; Scarpelli M; Bollito E
    Pathologica; 2001 Jun; 93(3):226-32. PubMed ID: 11433618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.
    Bostwick DG; Montironi R
    Virchows Arch; 1997 Jan; 430(1):1-16. PubMed ID: 9037309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
    Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
    Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
    Valotto C; Falconieri G; Pizzolitto S; Cerruto MA; Brondani G; De Gobbi A; Zattoni F
    Arch Ital Urol Androl; 2011 Jun; 83(2):78-82. PubMed ID: 21826879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
    van Gils MP; Hessels D; Hulsbergen-van de Kaa CA; Witjes JA; Jansen CF; Mulders PF; Rittenhouse HG; Schalken JA
    Prostate; 2008 Aug; 68(11):1215-22. PubMed ID: 18500693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Handling and pathology reporting of radical prostatectomy specimens.
    Montironi R; van der Kwast T; Boccon-Gibod L; Bono AV; Boccon-Gibod L
    Eur Urol; 2003 Dec; 44(6):626-36. PubMed ID: 14644113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers.
    Noguchi M; Stamey TA; McNeal JE; Nolley R
    J Urol; 2003 Aug; 170(2 Pt 1):459-63. PubMed ID: 12853799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.
    Heering M; Berg KD; Brasso K; Iversen P; Røder MA
    Surg Oncol; 2017 Mar; 26(1):21-27. PubMed ID: 28317581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.
    Sinnott M; Falzarano SM; Hernandez AV; Jones JS; Klein EA; Zhou M; Magi-Galluzzi C
    Prostate; 2012 Aug; 72(11):1179-86. PubMed ID: 22161896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
    Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C
    Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical prostatectomy specimens among Medicare patients in New York State: a review of pathologists' reports.
    Imperato PJ; Waisman J; Nenner RP
    Arch Pathol Lab Med; 1998 Nov; 122(11):966-71. PubMed ID: 9822124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.
    Inman BA; DiMarco DS; Slezak JM; Sebo TJ; Kwon ED; Leibovich BC; Blute ML; Zincke H
    Urology; 2006 Sep; 68(3):604-8. PubMed ID: 16979719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.